ASSOCIATION OF N-[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7- YL]METHYL-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N- METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL N-[(7S)-34-[420]-135--7-]-3-(78- -1245--3H-3--3-)-N--3--1

Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochlorid...

Full description

Saved in:
Bibliographic Details
Main Authors FELDMANN, Luc, VILAINE, Jean-Paul, THUILLEZ, Christian, FRATACCI, Marie-Dominique, ROUSSEL, Jrme, MULDER, Paulus, LEREBOURS-PIGEONNIERE, Guy
Format Patent
LanguageChinese
English
Published 15.04.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor.
Bibliography:Application Number: HK20150110660